Patents and scientific integrity

Concentration of Amphiphilic Molecules

By Paul Cole When inventors, whose background is overwhelmingly in science or engineering, become involved with the patent system, they are entering the domain of law which to them is a foreign country. The ninth commandment1 provides a useful guide through the unfamiliar country: its specific prohibition is against false testimony in a legal dispute, […]

Research Liasion: Corporate – University Research Alliances

By Michael D. Moberly A ‘research liaison’ should contribute to corporate – university (sponsored) research projects by: sustaining (protecting and preserving) unencumbered control, use, ownership and monitoring the value of both parties’ investments, i.e., the projected stream of intangible assets, IP, competitive advantages, and (proprietary) know how evolving from the research. Unfortunately, there’s a fairly […]

IP Strategy for Drug Discovery: A Dedicated Research Firm’s Perspective

By Vinita Radhakrishnan Given the nature of business of a dedicated research firm (DRF) in the pharmaceutical sector, intellectual property (IP), particularly, patents are considered to be the most valued asset. More times than not, the standing of a dedicated research firm, in the market place, is judged by the strength and nature of their […]

Patent strategy 101 – Keep it secret

By Pallavi Kharkar Do you have an invention ready in hand but are not able to file a patent? How will you protect it from being disclosed if you intend to eventually file a patent? Often disclosure is essential with partners, collaborators, investors, while developing advanced technologies with the help of external agencies and so […]

Getting the most from your IP agent networks

By Donal O’Connell IP agent networks stretch around the globe and through every industry sector. Donal O’Connell and Sabine Baum outline best practice for managing those networks and turning them into crucial business assets One of the most essential elements in supporting a global intellectual property (IP) portfolio is the network of IP agents and […]

Invention Report Template

By Donal O’Connell One simple yet effective way to build a level of discipline into the invention handling process is to define a standard template for invention reports coming from the inventor community.  If the idea is of potential value and is patentable, then the inventor should complete an invention report.  An invention report is […]

Low R&D Cost Per-Patent is a Poor Indicator of Good Return

By Bruce Berman Patent Yield-Per-R&D Dollar Varies Widely by Industry, Technology & Business Model For most businesses obtaining patents and costly R&D go together like love and marriage – you can’t have one with out the other. Or can you? The cost of R&D that underlies a particular invention varies greatly by industry, business model […]

Eight Species of Patent Strategy – Part 3 how intellectual property management develops from level 3 to level 4

By Bill Meade Intellectual Property Management in a Growing Soon-To-Be-Company: Once a growing company signs its first cross license with a balancing payment going out, or has a “near death experience” with IP litigation, and/or loses a patent litigation, IP management gains its first proposition with senior management.  The value of IP becomes intuitively obvious […]

Strategic intellectual property offshoring through outsourcing

By Fred Logue and Tony Owens Traditionally intellectual property (IP) offshoring has been used by multinational corporations as a way to reduce their global effective tax rates by holding their IP in low tax offshore jurisdictions. The 2009 relocation by McDonalds of its European head office to Geneva was reportedly motivated by the desire to […]

How to develop an IP Strategy: outline of steps

By Kate Wilson There is no question that an IP strategy should be aligned with business strategy. But, what needs to be better recognised is that IP issues can actually drive most strategic considerations in an organisation. For example, many pharmaceutical & chemical companies (Dow for example) focus their research on compounds for which they […]